REFERENCES
1. Egesie, O. J., Egesie, U. G., Jatau, E. D., & Odey, F. A. (2011). Seroprevalence of syphilis in pregnant
women attending antenatal clinic in a tertiary health institution in Nigeria. Asian Pacific Journal of
Tropical Medicine, 4(1), 79–82.
2. Endris, M., Deressa, T., Belyhun, Y., Moges, F., & Moges, B. (2015). Seroprevalence of syphilis and HIV
among pregnant women attending antenatal care clinics in southern Ethiopia. International Journal of
Infectious Diseases, 29, 95–100.
3. Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013). Untreated
maternal syphilis and adverse outcomes of pregnancy: A systematic review and meta-analysis. Bulletin
of the World Health Organization, 91(3), 217–226.
4. Hook, E. W., & Peeling, R. W. (2004). Syphilis control — A continuing challenge. New England Journal
of Medicine, 351(2), 122–124.
5. Korenromp, E. L., Rowley, J., Alonso, M., Mello, M. B., Wijesooriya, N. S., Mahiané, S. G., … Newman,
L. (2019). Global burden of maternal and congenital syphilis and associated adverse birth outcomes—
Estimates for 2016 and progress since 2012. PLOS ONE, 14(2), e0211720.
6. Muvunyi, C. M., & Dhont, N. (2012). Syphilis among pregnant women in sub-Saharan Africa: A review.
Open Infectious Diseases Journal, 6(1), 28–35.
7. Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N. S., Unemo, M., Low, N., … Temmerman,
M. (2013). Global estimates of the prevalence and incidence of four curable sexually transmitted
infections in 2012. PLoS ONE, 10(12), e0143304.
8. Peeling, R. W., & Hook, E. W. (2006). The pathogenesis of syphilis: The great mimicker, revisited.
Journal of Pathology, 208(2), 224–232.
9. WHO. (2016). WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva: World
Health Organization.
10. WHO. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021.
Geneva: World Health Organization.
11. Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines. MMWR
Recommendations and Reports, 64(3), 1–137.
12. Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013). Untreated
maternal syphilis and adverse outcomes of pregnancy: A systematic review and meta-analysis. Bulletin
of the World Health Organization, 91(3), 217–226.
(Supports statements on adverse pregnancy outcomes and the high risk of congenital syphilis when
maternal infection is untreated.)
13. Korenromp, E. L., Rowley, J., Alonso, M., Mello, M. B., Wijesooriya, N. S., Mahiané, S. G., & Newman,
L. (2019). Global burden of maternal and congenital syphilis and associated adverse birth outcomes—
Estimates for 2016 and progress since 2012. PLOS ONE, 14(2), e0211720.
(Provides global burden estimates and supports the argument about the continuing public-health impact
and the need for elimination efforts.)
14. Peeling, R. W., & Hook, E. W. (2006). The pathogenesis of syphilis: The great mimicker, revisited.
Journal of Pathology, 208(2), 224–232.
(Supports statements about asymptomatic/latent infection, natural history of syphilis, and diagnostic
limitations of symptom-based approaches.)
15. Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines. MMWR
Recommendations and Reports, 64(RR-03), 1–137.
(Supports recommendations for treatment, partner notification and public-health strategies.)
16. World Health Organization. (2016). WHO guidelines for the treatment of Treponema pallidum (syphilis).
Geneva: World Health Organization.
(Supports recommendations on benzathine penicillin treatment and WHO guidance to screen at first
antenatal contact.)
17. World Health Organization. (2021). Global progress report on HIV, viral hepatitis and sexually
transmitted infections, 2021. Geneva: World Health Organization.
(Supports statements about the global elimination agenda and progress/gaps in STI control.)